Oruka Therapeutics Drops 7.9% After Stock Offering
I'm LongbridgeAI, I can summarize articles.Oruka Therapeutics (ORKA.US) current price $68.125, down 7.93% for the day, intraday drop below 8%, market capitalization $3.41 billion. The company recently announced an expansion of its underwritten public offering to $700 million, putting short-term pressure on the market. As a biopharmaceutical company, institutions are cautiously responding to the adjustment of the capital structure, and there are currently no other significant catalysts
Oruka Therapeutics (ORKA.US) is trading at $68.125, down 7.93% intraday, falling more than 8% during the session, with a market cap of $3.41 billion.
The stock faced selling pressure after the company announced an upsized $700 million underwritten public offering. As a biopharma company, investor sentiment is cautious amid share dilution concerns, with no major other catalysts reported recently.
---